Tips to Organize the Digital Chaos with Alina Bridges, DO
In a world where she practices dermatology, conducts research, and is a super mom, Alina Bridges, DO has nailed down a strategy to not let emails stress her out.
Treating the Chest with Care on a Transgender Patient
A review on breast cancer screenings and procedures on the chest is essential to ensure proper gender-affirming care.
Establishing a Culture of Respect: Responding to Patient-Initiated Harassment
The impacts of discrimination, harassment, and microaggressions have lasting impact on a clinician’s performance, mental health, and career. Here’s how to create a respectful culture.
New Data Shows Promising Results in Treatment of Hand and Foot Atopic Dermatitis
The latest phase 3 trial results were showcased in an AAD late-breaking research session.
The Power of Patch Testing With Peggy Wu, MD
Wu delves into her AAD involvement as she presents in sessions centered around the importance of patch testing and how clinical guidelines are created.
Alina Bridges, DO Shares Importance of Immunofluorescence
She and her colleagues illustrated the role of direct immunofluorescence plays in the evaluation of autoimmune blistering disorders.
Top Takeaways from the 19th Annual Skin of Color Scientific Symposium
The Skin of Color Society challenged dermatologists, residents, and medical students to address racial disparities in dermatologic care and shared best practices to serve patients of color.
AAD 2023 Meeting Coverage to Look Forward To
The Dermatology Times® team is in New Orleans, Louisiana to showcase innovative solutions in dermatologic care.
Solutions for Challenging Mohs Reconstructive Surgeries
Anna Bar, MD, FAAD returns to AAD as part of the interactive “How Would You Reconstruct It?” session.
PREVIEW: 19th Annual Skin of Color Scientific Symposium
In conjunction with AAD 2023, the Skin of Color Society presents an opportunity to learn about racial disparities in dermatologic care and best practices to serve patients of color.
Confidence Confirmed for Atopic Dermatitis Treatment
Treatment safety and efficacy for atopic dermatitis has seen significant growth over the last decade.
New Study Shows Prevalence of Alopecia Areata in People of Color
The findings of this cross-sectional study indicate alopecia areata, alopecia totalis, and alopecia universalis is more common in people of color, particularly Asian Americans.
Allergan Aesthetics Partners with IFundWomen to Empower Entrepreneurship
The AbbVie company announced their partnership with the grant program to encourage women to own their own businesses.
FDA Reviewing Dupilumab for Chronic Spontaneous Urticaria
The treatment for adults and adolescents with the type 2 inflammatory skin condition has been accepted for FDA review.
Basal Cell Carcinoma Removed From President Biden’s Chest
The commander-in-chief’s cancerous tissue was successfully removed last month.
Looking at 5 Rare Skin Conditions
Today is Rare Disease Day. The Food and Drug Administration (FDA) defined a rare disease as a condition affecting less than 200,000 people in the United States.
IDP-126 Gel Shows Promising Results In Moderate-to-Severe Acne Treatment
Study participants saw a rapid decrease in inflammatory lesions with the once-daily antibiotic, antibacterial, and retinoid gel.
Aloha to Innovative Dermatologic Care: Reflecting on 2023 Winter Clinical Hawaii
Look back at 10 of the innovative sessions presented at the 2023 Winter Clinical Hawaii Conference in Kohala Coast, Hawaii.
Early-Stage Melanoma Testing Technology Launched in the United States
The AMBLor test is the first of its kind to identify the progression of melanomas.
Diep Bao Cream Recalled Following Elevated Blood Lead Levels in Infants
Shop Me Ca of Herndon, Virginia recalled its 10-gram tubes of Diep Bao Cream due to potential lead contamination.
Banana Boat Hair & Scalp Sunscreen Recall Expanded
An additional batch of sunscreen has been added to the recall first announced on July 29, 2022 for the presence of benzene.
Plaque Psoriasis and Work Productivity
A recent study shows patients with moderate-to-severe plaque psoriasis grew to be more productive at work with tildrakizumab treatment over time.
Aloha! Things to do While at Maui Derm Hawaii
Enjoy fun in the sun when Maui Derm Hawaii 2023 presentations aren’t in session.
New Investigational Topical Peptide Offers Promising Eczema Treatment
Cytokine-expressing genes were silenced in a recent Vanderbilt University Medical Center study.
FDA Clears Sofwave to Improve Appearance of Cellulite
The non-invasive treatment has no downtime for patients.
Study Finds Long-Term Safety and Efficacy for Roflumilast Cream for Chronic Plaque Psoriasis
The year-long study gives insight to the treatment’s efficacy and safety of durability.
Upadacitinb Gets a Green Light in Latest Atopic Dermatitis Study
Phase 3 studies show upadacitinib is safe in the treatment of moderate-to-severe cases of eczema.
Photodynamic Therapy is an Effective, Long-Term Treatment for Actinic Keratosis
2024 Expert Insights: More Options than Ever
FDA Gives Go-Ahead on Quoin Pharmaceuticals’ QRX003 Netherton Syndrome Study
Improving Skin Radiance and Luminosity